Project Grant F32AI186488
- This $457,875 Project Grant, awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research into the fundamental biology of the syphilis-causing bacterium Treponema pallidum (T. pallidum). The key objectives of this research are to investigate T. pallidum's nutrient acquisition mechanisms and cyclic nucleotide signaling pathways, which are critical to the pathogen's "stealth"...
- This Project Grant award of $440,000.00 from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), supports two key subprojects at the University of Texas Medical Branch at Galveston (UTMB): Developing a quantitative understanding of the processes involved when contractile injection systems (e.g. phage tails, tailocins, Type VI secretion systems) breach bacterial cell envelopes. This knowledge will be applied to...
- This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $556,510 to The Trustees of the University of Pennsylvania to conduct research focused on understanding the molecular mechanisms and evolutionary aspects of the rhoptry secretion system in unicellular eukaryotes, including apicomplexan parasites and non-pathogenic ciliates. The research program aims to unravel the...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $684,627 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Georgia State University Research Foundation Inc. to investigate the interactions between the bacteria that causes gonorrhea and the human host. The research aims to understand how the bacteria acquires nutrients and interacts with host cell glycans, with the goal of identifying new therapeutic targets to address the...
- This three-year Project Grant from the National Science Foundation's Division of Molecular and Cellular Biosciences totals $1,512,792 to fund research at Louisiana State University examining the gene regulatory networks affected by purine catabolites in bacterial pathogens. The research aims to identify additional transcription factors in Burkholderia thailandensis responsive to urate and xanthine, which accumulate in host tissues during infection due to production of reactive oxygen species....
- This Project Grant, awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $418,360 to the University of Texas Health Science Center at Houston to conduct systematic analysis of gene expression in the bacterium Treponema pallidum, which causes syphilis. The goal is to determine how different environmental conditions and host interactions impact T. pallidum gene expression, which could...
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $660,334 to Georgia State University Research Foundation Inc. to develop an innovative outer membrane vesicle (OMV)-based vaccine for protection against the pathogenic Neisseria gonorrhoeae (the causative agent of gonorrhea). The research aims to generate OMV vaccines expressing binding-defective derivatives of...
- This Project Grant award of $426,250.00 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to investigate the functions of two proteins, PEX4 and PEX22, in apicomplexan parasites. Apicomplexan parasites, such as Plasmodium falciparum (malaria) and Toxoplasma gondii (opportunistic infections), have major impacts on human health. The research team at Boston College will explore how...
- This federal Project Grant award of $243,750.00 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports research to investigate how the bacterium Gardnerella promotes the pathogenesis of Neisseria gonorrhoeae, the causative agent of the sexually transmitted infection gonorrhea. The research will use mutants of Gardnerella and N. gonorrhoeae, as well as human cell lines, to determine the mechanisms by which two Gardnerella...
- This $4,362,124 Cooperative Agreement award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 Allergy and Infectious Diseases Research) aims to advance the development of a promising vaccine candidate against Neisseria gonorrhoeae (NG), the causative agent of gonorrhea. The key products and services to be delivered include: Developing a combination NG vaccine using a meningococcal outer membrane vesicle (OMV) platform with adjuvants to induce broader protection...
INVESTINGATING THE MECHANISMS CONTROLLING NEISSERIA GONORRHOEAE TYPE IV PILUS DYNAMICS - PROJECT SUMMARY THE NEISSERIA GONORRHOEAE (THE GONOCOCCUS OR GC) TYPE IV PILUS (T4P) IS A CRITICAL COLONIZATION AND VIRULENCE FACTOR DURING PATHOGENESIS. T4P ARE USED TO ADHERE TO HOST CELLS AND PROMOTE COLONIZATION. T4P ARE DYNAMIC STRUCTURES MADE OF PILIN FIBERS THAT EXTEND AND RETRACT FROM THE BACTERIAL CELL. BEYOND HOST CELL ADHESION, T4P ARE INVOLVED IN A VARIETY OF CELLULAR PROCESSES INCLUDING DNA UPTAKE, TWITCHING MOTILITY, AND RESISTANCE TO ANTIMICROBIAL AGENTS. WE PREVIOUSLY IDENTIFIED A NOVEL COMPONENT OF THE GC T4P, TFPC. OUR PUBLISHED DATA ILLUSTRATED THAT TFPC IS REQUIRED FOR FULL PILIATION, AND PILIATION IS RESTORED IN TFPC MUTANTS LACKING THE PILT RETRACTION ATPASE. THERE ARE ELEVEN OTHER SUCH MUTANTS IN THE GC T4P. HERE, WE USE GENETIC, BIOCHEMICAL, AND BIOPHYSICAL TECHNIQUES TO DEFINE HOW TFPC CONTRIBUTES TO T4P DYNAMICS AND ARCHITECTURE. WE SHOW THAT WHILE TFPC IS REQUIRED FOR COMPLETE PILIATION OF GC, REMAINING PILUS STRUCTURES UNDERGO EXTENSION AT RATES SIMILAR TO PARENTAL STRAINS. HOWEVER, RETRACTION IS SLOWER IN STRAINS LACKING TFPC. FURTHERMORE, WE DEMONSTRATE THAT TFPC STABILITY IS DEPENDENT UPON THE PILQ SECRETIN. WE ALSO IDENTIFY AN IMPORTANT MOTIF WITHIN THE FLEXIBLE, DISORDERED, PROLINE-RICH REGION OF TFPC THAT IS IMPORTANT FOR FUNCTION OR STABILITY OF TFPC. I HYPOTHESIZE THAT TFPC INTERACTS WITH THE PILQ SECRETIN OR OTHER COMPONENTS OF THE T4P TO SUPPORT A SUBSET OF T4P. TO TEST THIS HYPOTHESIS, I WILL 1) DETERMINE IF TFPC INTERACTS WITH THE PILQ SECRETIN, 2) PERFORM STRUCTURE-FUNCTION ANALYSES OF TFPC, AND 3) INTERROGATING THE MECHANISM UNDERLYING REDUCED PILIATION IN TWELVE PILUS MUTANTS. THE PROPOSED RESEARCH IS SIGNIFICANT BECAUSE IT WILL DEFINE THE PREVIOUSLY UNCHARACTERIZED TFPC PROTEIN REQUIRED FOR PILIATION AND LINK ITS ACTIVITY TO OTHER PILUS COMPONENTS. IT WILL ALSO PROVIDE IMPORTANT INFORMATION FOR OTHER SPECIES T4P SYSTEMS AND POSSIBLY SOME TYPE II SECRETION SYSTEMS. THESE STUDIES EXPAND OUR CURRENT UNDERSTANDING OF T4P ARCHITECTURE AS WELL AS THE COMPONENTS GOVERNING MECHANISMS OF EXTENSION AND RETRACTION, PROVIDING A FOUNDATION FOR FUTURE STUDIES ON THE T4P DYNAMICS ESSENTIAL FOR COLONIZATION AND VIRULENCE. LONG-TERM, THE PROPOSED RESEARCH COULD PROVIDE NEW TARGETS FOR TREATING GONORRHEA INFECTIONS.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $75.5k | 9/1/25 |